PMS Escape Formulation Might Be Good For Stressed-Out Men, Too! When Swiss Medica goes shopping, don’t expect them to pay retail for the consumer health products they purchase. Since acquiring the O24/Sport product from insolvent German-based General Cosmetics, Swiss Medica (OTC BB: SWME) roared onto the radar screens of U.S. and Canadian pharmacy chains. Part two of their corporate strategy was the necessity of an encore product to avoid being called a “single product company.” Obtaining the North American licensing rights to PMS Escape overcame that hurdle. Internutria, which marketed PMS Escape in the mid to late 1990’s, sold more than $3.6 million of the product in about 25,000 stores, for the short time after it was launched in 1996.
However, a setback for Internurtria’s parent company, Interneuron Pharmaceuticals, Inc. (NASDAQ:IPIC), specifically a recall of Redux, forced the company to abort the launch of PMS Escape. In the same way Swiss Medica successfully revived the O24 product, lightning could strike twice in the form of PMS Escape’ reintroduction. Interviews with two key PMS Escape spokeswomen helped clarify which direction Swiss Medica might run with their newly acquired product.
Perhaps a PMS Escape makeover is in progress, in the same way O24/Sport morphed into the O24